Ghent University Academic Bibliography

Advanced

Brain plasmin enhances APP alpha-cleavage and A beta degradation and is reduced in Alzheimer's disease brains.

MD LEDESMA, JS DA SILVA, K CRASSAERTS, A DELACOURTE, B DE STROOPER and CG DOTTI (2000) EMBO REPORTS. 1(6). p.530-535
Please use this url to cite or link to this publication:
author
year
type
journalArticle (original)
publication status
published
journal title
EMBO REPORTS
EMBO Rep.
volume
1
issue
6
pages
530-535 pages
Web of Science type
Article
Web of Science id
000166006200017
ISSN
1469-221X
language
English
UGent publication?
yes
classification
A1
id
167488
handle
http://hdl.handle.net/1854/LU-167488
date created
2004-01-14 13:40:00
date last changed
2016-12-19 15:38:58
@article{167488,
  author       = {LEDESMA, MD and DA SILVA, JS and CRASSAERTS, K and DELACOURTE, A and DE STROOPER, B and DOTTI, CG},
  issn         = {1469-221X},
  journal      = {EMBO REPORTS},
  language     = {eng},
  number       = {6},
  pages        = {530--535},
  title        = {Brain plasmin enhances APP alpha-cleavage and A beta degradation and is reduced in Alzheimer's disease brains.},
  volume       = {1},
  year         = {2000},
}

Chicago
LEDESMA, MD, JS DA SILVA, K CRASSAERTS, A DELACOURTE, B DE STROOPER, and CG DOTTI. 2000. “Brain Plasmin Enhances APP Alpha-cleavage and A Beta Degradation and Is Reduced in Alzheimer’s Disease Brains.” Embo Reports 1 (6): 530–535.
APA
LEDESMA, M., DA SILVA, J., CRASSAERTS, K., DELACOURTE, A., DE STROOPER, B., & DOTTI, C. (2000). Brain plasmin enhances APP alpha-cleavage and A beta degradation and is reduced in Alzheimer’s disease brains. EMBO REPORTS, 1(6), 530–535.
Vancouver
1.
LEDESMA M, DA SILVA J, CRASSAERTS K, DELACOURTE A, DE STROOPER B, DOTTI C. Brain plasmin enhances APP alpha-cleavage and A beta degradation and is reduced in Alzheimer’s disease brains. EMBO REPORTS. 2000;1(6):530–5.
MLA
LEDESMA, MD, JS DA SILVA, K CRASSAERTS, et al. “Brain Plasmin Enhances APP Alpha-cleavage and A Beta Degradation and Is Reduced in Alzheimer’s Disease Brains.” EMBO REPORTS 1.6 (2000): 530–535. Print.